Skip to content

Drug interactions

Ondansetron + Rucaparib

Severity: Minor

Ondansetron and Rucaparib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib is a weak inhibitor of CYP3A4 (and CYP1A2, 2C9, 2C19), and ondansetron is cleared by several CYP enzymes. Exposure to ondansetron may rise slightly, but because several pathways contribute, the effect is unlikely to be clinically significant.

What this interaction means in plain words

Ondansetron and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ondansetron belongs to Gastrointestinal Tract; Rucaparib belongs to Oncology.

Evidence level: Low

Why it happens

Weak inhibition of CYP3A4 and CYP1A2 by rucaparib, which modestly reduces ondansetron metabolism.

What to do

No dose change is normally needed. Be aware of additive QT effects and ECG monitoring if other risk factors are present.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ondansetron and Rucaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ondansetron with Rucaparib?

MediHelp rates the interaction as minor. Ondansetron and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rucaparib is a weak inhibitor of CYP3A4 (and CYP1A2, 2C9, 2C19), and ondansetron is cleared by several CYP enzymes. Exposure to ondansetron may rise slightly, but because several pathways contribute, the effect is unlikely to be clinically significant.

How serious is the interaction between Ondansetron and Rucaparib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is normally needed. Be aware of additive QT effects and ECG monitoring if other risk factors are present.

What other medicines interact with Ondansetron?

MediHelp also lists interactions of Ondansetron with, for example, Apomorphine, Thioridazine, Vandetanib. The full list is on the Ondansetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in